UK GLP-1 Surge- What Clinics Must Know: Recent data from Grand View Research shows that GLP-1 users in the UK have jumped from 2.3% in March 2024 to 4.1% today The UK weight-loss GLP-1 market is projected to reach US$715 million by 2030, growing at a 17.7% CAGR from 2025 to 2030
Research coordinators who've guided hundreds of peptide protocols report that subjects attempting sublingual or oral Melanotan-2 administration discontinue within three to five doses more often than those using subcutaneous injection
This was very out of character, as this was not a generally fussy infant, and she had been perfectly healthy and happy until this moment
Among patients who qualified under existing indications, 74% had dyslipidemia, 62% had hypertension, 33% had prediabetes, 17% had obstructive sleep apnea, and 11% had cardiovascular disease
Another study suggested that the administration of L-theanine ameliorated the depression-like behavior of stress-challenged SAMP10 mice (59)